by NMS Group | Feb 18, 2026 | 2026, News
Milan, Italy, 18 February 2026 Benta has announced the acquisition of NerPharMa, a pharmaceutical manufacturing company located in Milan, Italy, from NMS Group. The acquisition marks a significant step in strengthening Benta’s European industrial platform and...
by NMS Group | Jan 12, 2026 | 2026, News
NERVIANO, Italy, BOSTON, Mass., SHANGHAI, China, 12 January 2026 – NMS Group (NMS), a global leader in oncological innovation, today announced that the China’s National Medical Products Administration (NMPA) has granted approval to the Investigational New...
by NMS Group | Nov 17, 2025 | 2025, News
Nerviano (Milan), Italy – Shanghai, China 17 November 2025 — Nerviano Medical Sciences (NMS), a clinical-stage biopharmaceutical company focused on oncology innovation, today announced that its subsidiary, Nerviano Medical Sciences (Shanghai) Co., Ltd. (NMS China),...
by NMS Group | Nov 7, 2025 | 2025, News
Nerviano (Milan), Italy, 7 November 2025 – Nerviano Medical Sciences S.r.l. (NMS), a member of NMS Group S.p.A. and a clinical-stage biotech company discovering and developing innovative therapies for the treatment of cancer, presented its poster at the World ADC...
by NMS Group | Oct 27, 2025 | 2025, Events, News
Nerviano Medical Sciences Srl is excited to announce its participation in BIO-Europe 2025, one of the premier partnering conferences for the global biotechnology and pharmaceutical industry. The event, taking place in Vienna, Austria, November 3–5, 2025, brings...
by NMS Group | Oct 2, 2025 | 2025, Events, News, Uncategorized
Nerviano Medical Sciences (NMS) ADC Business Unit Portfolio Head, Rosita Lupi, delivered an oral presentation at the Festival of Biologics in Basel (30/09/2025): “Reinventing Cytotoxins and Targeted Molecules as Next-Generation Payloads for ADCs.” The session was very...
Welcome and Check out our new motion picture!
Recent Comments